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Fluorescence Spectroscopic Studies on Phase Heterogeneity
in Lipid Bilayer Membranes
Winchil L. C. Vaz1,3 and Eurico Melo2
There is a growing interest in functional membrane heterogeneity on the mesoscopic (several tens
to hundreds of molecular dimensions) scale. However, the physical–chemical basis for this sort of
heterogeneity in membranes is not entirely clear. Unambiguous methods to demonstrate that the
cell plasma membrane and other cellular membranes are in fact heterogeneous on the mesoscopic
level are also not generally available. Fluorescence techniques do, however, provide excellent tools
for this purpose. In particular, the emerging techniques of scanning near-field optical microscopy
and single-molecule fluorescence microscopy hold a great deal of promise for the near-future. All
these methods require the use of fluorescent probes (lipids and/or proteins) and a clear definition
of how these probes partition between domains of coexisting membrane phases. The development
of the concept of membrane heterogeneity over the years since the first proposal of the “fluid
mosaic” model is reviewed briefly. The use of lipid-binding proteins in experimental protocols for
the labeling of membranes with fluorescent lipid amphiphiles as monomers in aqueous solutions
at concentrations well above their critical aggregation concentrations is discussed. The methods of
fluorescence spectroscopy available to the cell biologist for determining probe partition coefficients
for partitioning between coexisting membrane phases are reviewed in some detail, as is the relevant
theoretical and experimental work reported in the literature.
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INTRODUCTION to be the base structures of the biological membrane. It
was natural that the process should also have led, as it
Our present understanding of the way biological did, to a considerable increase in our understanding of the
membranes function owes a considerable debt to the vast properties of various hydrated phospholipid mesophases.
amount of literature generated by the scientific commu- Today, almost 30 years since the proposal of the fluid
nity after the proposal of the “fluid mosaic” model [58] mosaic model, the attention of the interested scientific
for biomembrane structure and dynamics. A very consid- community is being dominated by the relevance of the
erable fraction of this literature was devoted to the proper- physical structure of the phospholipid bilayer matrix of
ties of lipid bilayer membranes since these were the biological membrane to cell physiology.
understood, within the context of the fluid mosaic model, From a physical–chemical perspective we may view
the biological membrane as a quasi-two-dimensional fluid
solution that forms an interface between two bulk three-1 Departamento de Quı´mica, Universidade de Coimbra, 3004-535 Coim-
bra, Portugal. dimensional aqueous solutions: the intracellular solution,
2 Instituto de Tecnologia Quı´mica e Biolo´gica, Universidade Nova de or cytoplasm, and the extracellular solution; or two intra-
Lisboa, 2784-505 Oeiras, and Instituto Superior Te´cnico, 1049-001
cellular compartments. The quasi-two-dimensional fluidLisboa, Portugal.
solution that we call the membrane can be viewed as a3 To whom correspondence should be addressed. Fax: Int 1 351
239827703. E-mail: wvaz@ci.uc.pt fluid solvent composed of two leaflets, each with the
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thickness of the mean length of the constituting lipids,
in which all other membrane components are dissolved
or to which they are adsorbed due to the effect of a variety
of forces which range from purely surface electrostatics
to solvation of limited parts of the solute molecules (lipid-
attached proteins or amphipathic helices, for example).
Viewed in this manner, it becomes important to under-
stand the nature and properties of the solvent. One of the
first questions that naturally arises is whether or not the
solvent is homogeneous. The fact that each leaflet of
the lipid bilayer of a membrane is composed of several
chemical constituents [45] leads us immediately to con-
sider that the solvent could be a physically heterogeneous
system [19]. Although this was not explicit in the proposal Fig. 1. A modified version of the fluid mosaic model of Singer and
of the fluid mosaic model, the possibility that “some Nicolson (1972), which includes the concept that phase separations in
significant fraction of the phospholipid is physically in the cellular membranes could result in a heterogeneous system with
coexistence of domains of several different kinds of lipid phases.a different state from the rest of the lipid” was not specifi-
Adapted with permission from Vaz and Almeida (1993) and Vaz (1994).cally excluded from the proposal. Very early work from
the laboratories of McConnell [77] and Sturtevant [36]
clearly established that lipid miscibility in hydrated phos-
pholipid bilayers was often nonideal and that this nonide- structures, insoluble at low temperatures in Triton X-100
micelles, which have been equated with sphingolipid- andality sometimes extended to states in which all
constituents were in a fluid state. Since that pioneering cholesterol-rich domains, termed “rafts,” in the original
membranes (for reviews on rafts see Refs. 8–10,25,50,56,work, the publication of several phase diagrams of
hydrated lipid bilayers composed of binary or higher- and 57). While the conclusion that detergent insolubility
necessarily means plasma membrane heterogeneityorder mixtures of lipids [37] has justified the conclusion
that “lipid miscibility in a lipid bilayer is more the excep- resulting from lipid immiscibility may be questioned on
the basis of very fundamental principles of phase behav-tion than the rule” [67].
A heterogeneous lipid bilayer as the basic matrix of ior, the recent literature in cell biology and biophysics
seems to have accepted rafts as a fact, and almost everya biological membrane is an attractive concept in that it
could lead to an effective “compartmentalization” of the result that can be attributed to a heterogeneity of a biologi-
cal membrane [48,52] is today attributed to rafts in onemembrane, a phenomenon that has its counterpart in the
whole cell, with well-documented consequences for cel- form or another. Be that as it may, it is gratifying to
see that there is a generalized acceptance of functionallular metabolism and physiology. It is, therefore, not sur-
prising that proposals for a membrane structure with heterogeneity in cell membranes, something that, retro-
spectively, probably should never have been doubted and,coexisting immiscible domains at the level of the lipid
bilayer arise at a very early stage in the post–fluid mosaic as mentioned above, has been suggested by several work-
ers since the early 1970s.era [24,26,27,44,62]. Interpretation of our results on the
long-range diffusivity of fluorescent lipid derivatives in Having accepted that biological membranes may be
heterogeneous, it becomes incumbent to demonstrate thismultiphase lipid bilayers in terms of two-dimensional
percolation [1–3,11,65–67,70,71] led us to propose that in an unambiguous and direct manner. This is particularly
important if functional consequences are attributed tobiomembranes could make use of the interesting conse-
quences of phase heterogeneity and the resultant compo- membrane heterogeneity. Direct demonstration of a struc-
ture usually involves visualization of the same by somenent compartmentalization [68] if they were themselves
“domain mosaics” [40,63,66–69], and a modification of sort of microscopy. For biological membrane structures
with dimensions that are smaller than the limits of opticalthe fluid mosaic model was proposed to include these
concepts [66,69] (see Fig. 1). resolution, electron microscopy [generally after freeze-
fracture (see, e.g., Ref. 62)], atomic force microscopyDifferential solubilization of plasma membranes in
detergent solutions has been used increasingly as evi- [20], and near-field scanning optical microscopy [21,23]
become the methods of choice because of their high reso-dence in support of the existence of cell membrane hetero-
geneity. This differential solubilization results in the lution. Microscopic techniques that involve measurement
of single-particle or domain diffusivities [48,52], whileisolation of sphingolipid- and cholesterol-rich bilayer
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being relatively straightforward in their interpretation, The spectral characteristics of the fluorophore
should be such as to be clearly distinguishable from cellu-though not simple to perform, cannot be said to be direct
and unambiguous demonstrations of membrane heteroge- lar autofluorescence, which generally implies molecules
that absorb and fluoresce at wavelengths above 500 nm.neity. Besides, in these techniques, it is fundamental to
know how the probes used behave within the membrane A high molar extinction coefficient, emission quantum
yield, and photochemical stability are also desirable char-in which they are being visualized. Electron microscopy
and atomic force microscopy provide relatively static acteristics. Ideal excited-state lifetimes and the limiting
polarization, r0, of the fluorophore depend very muchviews of the system under investigation and require
clearly definable differences in surface topology or order upon which characteristic of the membrane microenviron-
ment is to be probed. The charge of the fluorescent deriva-(or rigidity, in the case of atomic force microscopy)
between the coexistent membrane phases so as to permit tive in the polar membrane interface is also a
characteristic that may not be ignored when membranethem to be distinguished from each other. In the long
term, and considering that single living cells are the even- compositions that include charged lipids or domains rich
in charged lipid constituents are being examined. Fortual object of study, near-field scanning optical micros-
copy seems to provide the best choice for the study of cellular membranes this becomes a very important prop-
erty of the fluorescent “stain.”membrane heterogeneity in situ. The method is, however,
still not at a stage of technical development that makes If staining is done with FLAs, i.e., amphiphiles,
whether or not derived from membrane lipids, the natureit generally useful, but this may be only a matter of time.
While freeze-fracture electron microscopy and atomic of the apolar portion of the molecule is of importance
since this may determine the partitioning of the probeforce microscopy do not require probes, near-field scan-
ning optical microscopy does. Its successful utilization between ordered and disordered membrane domains and
thus determine their utility as stains for detecting andis, therefore, also dependent upon the detailed and quanti-
tative characterization of the probe interaction with the quantitatively describing this type of phase coexistence
(see below).membrane phases, and it is this aspect that we review here.
HOW ARE AMPHIPHILES ADDED TO
PROBES FOR MEMBRANE MICROSCOPY CELLULAR MEMBRANES?
Fluorescent lipid amphiphiles (FLAs) are the idealIdeally, probes of any sort should be intrinsic to the
system under study so that there can be no doubts about stains for cell membranes when the visualization of coex-
isting lipid phases in them is desired [5,29]. As a simplis-perturbative effects. This is, however, usually an utopic
requirement, and most useful work has, in the past, been tic first approximation, an aqueous solution of the FLA
may be added to a cell culture, the expectation being itsthe result of using extrinsic probes whose perturbation
of the system is minimal and/or adequately understood. spontaneous association with the cell membrane. The
amount of FLA that associates with the cell membranesFor optical microscopic applications, membrane probes
are fluorescent molecules that are attached to the mem- will be a function of its total concentration in the aqueous
phase and the membrane/water partition coefficient (KP),brane proteins either directly by covalent attachment or
indirectly as fluorescently labeled antibodies that specifi- which will be different for different amphiphiles. But
amphiphiles form molecular aggregates (micelles, micro-cally bind certain molecules in the membrane. Alterna-
tively the fluorescent molecules partition preferentially crystals) at some critical aggregation concentration (CMC
or solubility product, if sparingly soluble) which dependsinto the membrane as a consequence of their apolarity
and report on its properties. Fluorescent lipid amphiphiles upon the nature of the polar and apolar portions of the
molecule and can be quite low. In fact, the more similar(FLAs) (see list of abbreviations in the Appendix) fall
into this class of membrane “stains.” These consist of a an amphiphile is to a naturally occurring lipid in its behav-
ior, the lower its CMC is likely to be. Intense local stainingfluorophore covalently attached to an amphiphilic carrier
which may be (ideally is) a derivative of a membrane will result if an aggregate comes in contact with a cell
surface and fuses with it [4]. Obstruction of free laterallipid. The fluorophore itself may be part of the apolar
(acyl chains substituted by an apolar fluorophore such as diffusion of the FLA in the plane of the surface, which
we may suppose to be the plasma membrane, will thenDPH, pyrene, anthroyl, carbazole, or indole groups) or
polar (headgroups are modified using any one of several result in an apparent membrane inhomogeneity that is
not a physical property of the membrane but an artifactrather polar fluorophores) portion of the molecule.
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of the staining procedure. This problem does not exist, as a function of CA for various values of CP and KA.
Knowledge of the CMC for the FLA will then permit ushowever, if the stain is able to access the target membrane
only as a monomer. In practice this will be the case if to estimate whether or not the goal of its monomerization
in aqueous solution has been achieved.the FLA is added to the target membrane as an aqueous
solution at a concentration below its CMC. Such a proce- Having monomerized the FLA in aqueous solution,
its transfer to the cell surface membrane will depend upondure has two drawbacks: (1) the CMC could be too low
to permit significant staining within a practically useful the following competing equilibria:
time; and (2) the higher the value of the CMC, the lower
the value of KP is likely to be, which means that the Aw 1 P s
KA
PA
likelihood of the FLA desorbing from the membrane
surface and eventually reinserting into some other mem- Aw s
KP
ALbrane or membrane phase could be quite high. Also, the
nonnegligible concentration of FLA in the aqueous phase The velocities for binding and desorption from the mem-
may give rise to a nondesirable fluorescence background. brane surface can be written
This would imply that the stain will eventually (the proc-
v1 5 k1[Aw]SL and v2 5 k2[AL]SL (1)ess can be quite rapid, depending on the desorption and
association rate constants) be distributed in all accessible and the equilibrium partition coefficient, KP, for FLA
membranes and not be limited to just the targeted one. partitioning between the membrane phase and the aque-
Another approach to the monomerization of an FLA ous phase is given by
in aqueous solution is to present it as a protein-bound
species.4 In this case the two FLA species encountered KP 5
k1
k2
5
[AL]
[Aw]
(2)
in solution are, ideally, the monomer in aqueous solution
and the protein-bound form, which are in equilibrium The suffixes 1 and 2 refer, respectively, to the binding
with each other. In general, the total amount of FLA
and desorption processes, k are the rate constants, SL isadded to the cells to be stained will typically be based
the area of the lipid (membrane) phase referred to the
upon the desired level of staining (moles of amphiphile
total volume of the reaction mixture, and CS is the surfaceper unit of cell membrane surface), the total membrane
concentration (moles per unit area) of the FLA in the
area to be stained, and KP for the amphiphile partitioning
membrane phase. It can be shown that at equilibrium CSbetween the membrane and the aqueous phases. The is related to CA, CP , KA, and KP by the expressionamphiphile-binding protein must be at a concentration
that, in consideration of the FLA/protein equilibrium
CA 5 CS 1SL 1 1KP 1
KACP
KP 1 KACS2 (3)association constant, KA, assures that the concentration
of free amphiphile at equilibrium is below its CMC. Using
the Mass Action Law for the equilibrium (assuming a Figure 3 shows some results for the expected FLA density
in the target membrane as a function of the total FLAsingle binding site on the protein),
concentration. The values of the FLA density in the target
membrane are relatively insensitive to CP and KA.Aw 1 P s
KA
PA
Determinations of the CMC of amphiphiles in aque-
ous solutions have been described for values of CMC aswhere AW, P, and PA are the FLA in aqueous solution,
the lipid-binding protein, and the protein–FLA complex; low as 10216 [49,60], and the same methodology would,
in principle, be applicable to solutions of FLAs as well.the equilibrium association constant KA 5 [PA]/[AW][P],
where the equilibrium concentration of free FLA in aque- A simpler method, however, could be via utilization of
the spectroscopic properties of the FLAs themselves sinceous solution [AW] 5 CA 2 [PA], and the equilibrium
concentration of free protein in solution [P] 5 CP 2 [PA]; the fluorescence properties are usually different for the
monomer in aqueous solution and in the micelle (aggre-and CA and CP are the total concentrations of FLA and
protein, respectively. Figure 2 shows the variation of [AW] gate). As an example we present the determination of the
CMC (4.2 3 1029 M ) of NBD–diC14:0PE obtained by
simple measurement of the concentration-normalized flu-
4 This method is quite generally used and is, to the best of our knowledge, orescence emission intensity as a function of the FLA
based upon a protocol from the laboratory of Dr. Richard E. Pagano. concentration (Fig. 4) (M. Abreu, unpublished results).
We are not aware of any quantitative studies concerning the binding FLAs may also be introduced via metabolic path-
of most of the FLA used to albumin or of any quantitative studies
ways into cell membranes (Ref. 64 and referencesconcerning the transfer of these albumin-bound amphiphiles from the
albumin-binding site to the membrane surface. therein), a method that may merit closer study.
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Fig. 2. Effect of an FLA-binding protein upon the equilibrium concentration of the free FLA in aqueous solution (A). The curves are, from bottom
to top, for [P] 5 3 3 1025, 1 3 1025, 3 3 1026, 1 3 1026, 3 3 1027, and 1 3 1027 M FLA-binding protein. KA is assumed to be 1 3 106 in all
cases. (B) As a function of the equilibrium association constant for the association of the FLA to the FLA-binding protein. The curves are, from
bottom to top, for KA 5 1 3 108, 1 3 107, 3 3 106, and 1 3 105. The concentration of the FLA-binding protein is 1 3 1025 M in all cases.
DETERMINATION OF PROBE (STAIN) brane has two phases in coexistence and the FLA is totally
insoluble in one of them, clearly the FLA will residePARTITIONING BETWEEN COEXISTING
MEMBRANE PHASES exclusively in the second phase and its utility is unambig-
uous. To the best of our knowledge this extreme situation
is obtained only when one of the phases is a pure gelOnce the FLA stain is in a membrane its distribution
within this structure will depend upon its partition coeffi- phase (see, e.g., Refs. 28 and 41). For all other situations,
cient between different coexisting phases. If the mem- when two fluid phases coexist, the FLAs have some finite
nonzero value for the interphase partition coefficient,
KP(L).
It can be imagined that more than two phases could
coexist in a given cell plasma membrane. However, the
only situation susceptible to an analytical solution con-
cerning which domains have which probe and in what
amount is one in which the membrane heterogeneity is
assumed to result from just two phases in coexistence
with each other. Numerical solutions may, however, be
possible for cases in which more than two types of
domains coexist. For quantitative examination of natural
membrane heterogeneity using FLAs, we have to know
the value of KP(L). This can be determined only in a model
system that is known to consist of the two phases expected
to exist in the target cell membrane. The phase diagram
of the model membrane system must also be known.
Davenport [13] has recently reviewed some of theFig. 3. FLA density in a target membrane as a function of the total
fluorescence spectroscopy techniques that can be used toFLA concentration. A cell density of 1 3 106 cells/ml, KA 5 1 3 106,
KP 5 1 3 108, and [P] 5 1 3 1025, M were assumed. study the partitioning of fluorophores between coexistent
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from fluorescence quenching experiments must consider
that both the FLA and the quencher have their own spe-
cific KP(L) and translational diffusion coefficients. In addi-
tion, the unquenched lifetimes of the FLA in the different
phases could be different; dimensional effects (in particu-
lar, effects related to two-dimensional diffusion and topol-
ogy of the diffusional space) are likely to make an exact
analysis extremely complex. Dynamic quenching of fluo-
rescence also restricts us to the use of FLAs with chromo-
phores that have a long excited-state lifetime if we want
to avoid the use of very high quencher concentrations.
KP(L) can, in principle, be determined quantitatively by
quenching experiments only when quenching in one of
the phases is complete and an exclusively static process.
Fluorescence Lifetime. In the absence of other com-
plicating effects the decay of fluorescence, F(t), of an
FLA that partitions between two phases follows a double-
exponential law:
F(t) 5 a1 exp(2t/t1) 1 a2 exp(2t/t2) (5)
In the more common case, where multiexponential decay
Fig. 4. Determination of the critical aggregation concentration of NBD– in pure phases is observed, the equations presented hereaf-
diC14:0PE. The concentration-normalized fluorescence intensity is ter need to be adequately adapted. For reliable amplitudes,
defined as the fluorescence intensity measured for a given concentration ai , and lifetimes, ti , to be extracted, the fluorescencedivided by that concentration. The absorbances of the solutions used lifetimes in the two phases, determined independently,for fluorescence intensity measurements are such that the inner filter
should be sufficiently distinctive, e.g., t2/t1 . 1.5 [34].effect is negligible. Reproduced with the kind permission of Magda
Abreu. Both the absorption and the emission spectra of A
may be different in shape and intensity when A is in
phases 1 and 2, as in the idealized case represented in
Fig. 5, in which the fluorescence intensities measured at
phases in membranes. In general, if there are Ai molecules lem have to be corrected for the different absorptions at
of an FLA in phase i with area fraction xi , the partition the excitation wavelength, lex, and the emission intensity.
constant, KP(L), is defined as Supposing that the amount of FLA not attached to
the membrane is negligible (the emission observed arises
A2 s
KP(L)
A1 only from membrane-bound FLA), and for very low
absorbance values, the number of quanta absorbed by the
and is given by
solution, I lexi , is proportional to the molar absorptivity at
the wavelength, e lexi ,KP(L) 5
[A1]
[A2]
(4)
I lex1 5 be lex1 [A1]x1 (6)
where [Ai] refer to the concentration of the FLA in a I labs2 5 be lex2 [A2](1 2 x1)given phase as moles per unit area of that phase, taking
the thermodynamic standard state as the unit molar con- b being a constant of proportionality. The relative inten-
centration per unit area. Several observable fluorescence sity of fluorescence emission observed at lem for t 5 0
parameters can be used to determine KP(L): fluorescence will then be
intensity variations at a given wavelength due to spectral
shifts and/or quantum yield variations, fluorescence life- a1
a2
5 g
kf1 e lex1 [A1]1 x1
kf2 e lex2 [A2]2(1 2 x1) 5 g
kf1 e lex1 x1
kf2 e lex2 (1 2 x1) KP(L)time variations between coexisting phases, decomposi-
tion of fluorescence emission spectra arising from FLAs (7)
in different phases, differences in the emission anisotrop-
ies between different phases, and fluorescence quenching. where kfi is the radiative rate constant in each environ-
ment, obtained from the FLA lifetime and quantum yieldQuantitative analysis of the experimental results obtained
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difference between the two lifetimes is sufficiently large
for them to be resolved.
Emission Anisotropy. In analogy with what is done
in the fluorescence lifetime method we also observe the
fluorescence anisotropy at a given wavelength lem with
excitation at a wavelength lex, as represented in Fig. 5.
Due to the additivity property of the fluorescence anisot-
ropy [74], the total fluorescence anisotropy, r, is
r 5 r1 f1 1 r2 f2 (9)
where ri are the anisotropies of the fluorescence emitted
by Ai , and fi the fraction of the total emission intensityFig. 5. Idealized absorption and emission spectra of a FLA showing
at lem originating from the molecules in each medium.the molar absorptivities, e i , at the excitation wavelength, lex, and the
In Eq. (9) the fraction of fluorescence emitted byrelative fluorescence intensity, Fi , at lem.
Ai is given by
fi 5
F lemi
F lem1 1 F lem2in the pure phases (by definition, kf 5 Ff /t); g 5
ylem1 /ylem2 corrects for the intensity of fluorescence at the
emission wavelength of component i; and ylemi 5 fluores- 5
e
lexi [Ai]xi Fi ylemi
e
lex1 [A1]x1F1 ylem1 1 e lex2 [A2](1 2 x1)F2 ylem2 (10)cence intensity collected at lem/total fluorescence inten-
sity of A in phase i.
and in terms of KP(L) it may be rewritten for phase 1 asIn the region where the two phases coexist the decays
of the FLA excited state in each of the coexisting phases f1 5 jKP(L)
x1
1 2 x1Y11 1 jKP(L) x11 2 x12 (11)follow Eq. (5), and if all the other parameters are known,
a global analysis of the biexponential decays imposing
the relation between preexponentials from Eq. (7) will where j 5 e lex1 ylem1 F1 /e lex2 ylem2 F2.
have KP(L) as the only adjustable parameter. The proviso The same algebra for phase 2 leads to
that “all the other parameters are known” is, for the
present case, difficult to satisfy except when we have f2 5 1/11 1 jKP(L) x11 2 x12 (12)experimental evidence that the absorption and fluores-
cence emission spectra of the FLA do not shift or change
and substituting in (9), we obtainin shape with the transfer of the FLA between phases,
for which case Eq. (7) is reduced to
r 5 1r1jKP(L) x11 2 x1 1 r22/11 1 jKP(L)
x1
1 2 x12 (13)a1
a2
5
kf1x1
kf2(1 2 x1) KP(L) (8)
From Eq. (13) the values of ri are readily obtained
if we know j, the ratio of the fluorescence intensities atThe absence of spectral change is a condition that
is difficult to observe because, in general, a significant lem of two samples of pure phases 1 and 2 with the same
FLA concentration excited at lex. If the isosbestic anddifference in the lifetime results either from a change in
the nature of the lowest excited singlet state or from the isoemissive wavelengths are known, then the best solu-
tion is to use them, making j 5 1.tuning of the energy of the excited singlet state relative
to that of a neighboring triplet state, both implying a Fluorescence Quantum Yield. Some FLAs have a
strong environment-dependent fluorescence quantumlarge spectral change and, most probably, quite different
kf values. yield that is frequently accompanied by a change in the
shape of the absorption and emission spectra. From Eq.The method of fluorescence lifetime variation
described should be, in the case where Eq. (8) applies, (6) we may easily conclude that, in the case where the
fluorescence arising from FLA not included in the mem-the most expedient of all. In practice, only a restricted
number of chromophores allows a reliable and consistent brane is negligible, the total intensity of the fluorescence
observed is the sum of the total fluorescence arising fromanalysis of the decay data obtained, even when the decay
from each phase is a clean single exponential and the each of the phases (see Fig. 5), which may be equated as
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F lem1 5 ae lex1 [A1]x1 ylem1 F1 (14) at equilibrium, of an FLA between two populations oflipid vesicles (or other form of bilayer membranes), each
F lem2 5 ae lex2 [A2](1 2 x1)ylem2 F2 of which represents one of the phases to be studied or (b)
by measuring KP, the lipid-phase/aqueous-phase partitionwhere a is a constant depending on the geometric charac-
coefficient, for each of the lipid phases independentlyteristics of the experimental setup and sample. The value
(KP1, KP2) and using the expressionof KP(L) may be obtained from the ratio of the emission
intensity of the same FLA concentration in a mixture of
phases, I, to that in a pure phase, for example, phase 2, KP(L) 5
KP1
KP2
(16)
I2, using Eq. (15):
All of these approaches have been used in the literature;I
I2
5 1 1 jKP(L)
x1
1 2 x1
(15)
all have some advantages and some disadvantages. Since
KP(L) is an equilibrium thermodynamic quantity, it is nec-Again, the experimental methodology is straightfor-
essary to ensure that the system on which a measurement
ward once the value of j is known, and choosing the is being made is at equilibrium. Direct determination of
excitation and emission wavelengths coincident with the KP(L) leaves no ambiguity about the identities of theisosbestic and isoemissive points greatly simplifies the phases that do in fact coexist in the membrane of interest
task. but requires the availability of good phase diagrams for
Spectral Distribution. The analysis for obtaining the
estimation of the mass (or molar) fractions of coexisting
concentrations in each coexistent membrane phase is
membrane phases. The indirect methods are experimen-
straightforward, once the two emission spectra in the two tally simpler to execute but require that some precautions
pure phases are known for the same concentration of FLA. be taken. In the equilibration of FLA between two mem-
brane vesicle populations, for example, care must be taken
to ensure that there is no mixing of components of the
EXPERIMENTAL RESULTS ON FLA two membrane populations other than the FLA whose
PARTITIONING BETWEEN PHASES IN MODEL behavior is to be studied. This approach, therefore,
SYSTEMS excludes studies on FLAs whose KP very strongly favors
the lipid phase compared to the aqueous phase since the
exchange of these molecules between the two vesicleIn Table I we have compiled some of the available
data on fluorescent probe partitioning between membrane populations is likely to be very slow, if not just as slow
as the exchange of host membrane lipid componentslipid phases. Only data that have a numerical value for
KP(L) are included in the table. Most of the information themselves. In studying the partitioning of FLA between
an aqueous phase and a lipid membrane phase, the exis-available in the literature in this regard has to do with
the partitioning of FLA between solid or gel (s) and tence of micellar aggregates or other form of aggregates
in the system at equilibrium also may not be ignored.liquid-disordered (ld) phases, and a very small fraction
concerns partitioning between liquid-ordered (lo) and ld Three methods have dominated in the determinations
of KP(L) reported in the literature for membrane phasesphases. No information is available for KP(L) between s
and lo phases. Phase separations of the lo/ld type or even that coexist with each other in the same lipid bilayer: (1)
steady-state fluorescence emission intensity or quantumof the type in which two immiscible lo phases coexist in
the same membrane may, however, be the most biologi- yield determination; (2) steady-state fluorescence polar-
ization or anisotropy measurements, and (3) staticcally relevant form of membrane heterogeneity and
include “raft” domains. However, since knowledge of quenching of FLA fluorescence. In the “indirect” meas-
urement of KP(L), i.e., by separate measurement of KPKP(L) is essential for the eventual application of quantita-
tive microscopy to inhomogeneities in cell plasma mem- between the individual lipid phases and the aqueous phase
or by measurement of the equilibrium partitioning of anbranes, we review the reported work due to its
methodological value. FLA between the two phases existent as separate popula-
tions of lipid vesicles, difference absorption spectroscopyIn terms of methodology, two fundamentally differ-
ent approaches to the determination of KP(L) are possible: between FLA in the aqueous phase and FLA in the mem-
brane-bound state [59] and direct measurements of inser-(1) KP(L) can be determined directly for partitioning
between two phases that coexist in the same lipid bilayer tion and desorption rate constants of an FLA monomer
into/from a membrane surface from/to an aqueous phasemembrane; and (2) KP(L) can be determined indirectly by
one of two methods—(a) by quantifying the distribution, [47] have been used.
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Table I. Summary of the Partition Coefficients (KP(L)) Reported in the Literature for the Partitioning of Fluorescent Lipid Amphiphiles Between
two Lipid Phasesa,b
Probe Ref.c Host phase Type T (8C)d Method of determination KP(L)
Perylene 1 DiC18:0PC/diC16:0PC s/ld Fluorescence emission intensity ,1
1 DiC16:0PE/diC16:0PC s/ld Fluorescence emission intensity ,1
DPH 2 DiC16:0PC/diC14:0PC s/ld 28 Steady-state fluorescence anisotropy 0.97 6 0.04
(equilibrium partitioning between 1.04 6 0.04
pure phase liposomes)
3 DiC16:0PC/SL-PC s/ld 23 Fluorescence quenching 0.5–1
4 Ca(diC18:1PS)2/SL–PC s8/ld 26 Fluorescence quenching 0.08 6 0.01
(excess Ca2+)e
5 Egg PC/SL–PA (excess s8/ld (a) Fluorescence quenching 1
Cd2+)
6 DiC16:0PC/SL–PCe s/ld 25 Fluorescence quenching 0.67 6 0.22
6 DiC18:0PC/SL–PCe s/ld 25 Fluorescence quenching 0.67 6 0.22
7 DiC18:0PC/diC14:0PC s/ld 32–44 Steady-state fluorescence anisotropy 0.303
(b)
TMA–DPH 7 DiC16:0PC/diC14:0PC s/ld (a) Steady-state fluorescence polarization 0.313
(equilibrium partitioning between
pure phase liposomes)
tPnA 8 DiC16:0PC/C16:0C22:6PC s/ld 22 Absorption spectroscopy (derived from 2.9 6 0.7
lipid-phase/aqueous-phase
partitions)
8 DiC16:0PC/C16:0C22:6PC s/ld (a) Steady-state fluorescence polarization 5.1 6 1.2
8 DiC16:0PC/C16:0C22:6PC s/ld (a) Fluorescence emission quantum yield 3.4 6 0.7
9 DiC16:0PC/C16:0C22:6PC s/ld (b) Steady-state fluorescence polarization 4.9 6 2.3
9 DiC16:0PC/C16:0C22:6PC s/ld (b) Fluorescence emission quantum yield 6.3 6 4.1
4 Ca(diC18:1PS)2/SL–PC s8/ld 26 Fluorescence quenching 0.33 6 0.11
(excess Ca2+)e
10 DiC16:0PC/C16:0C22:6PC (b) Steady-state fluorescence polarization 5.2 6 1.9
10 DiC16:0PC/C16:0C22:6PC (b) Fluorescence emission quantum yield 5.8 6 3.0
cPnA 8 DiC16:0PC/C16:0C22:6PC s/ld 22 Absorption spectroscopy (derived from 0.6 6 0.2
lipid-phase/aqueous-phase
partitions)
8 DiC16:0PC/C16:0C22:6PC s/ld (a) Steady-state fluorescence polarization 0.6 6 0.1
8 DiC16:0PC/C16:0C22:6PC s/ld (a) Fluorescence emission quantum yield 0.8 6 0.3
9 DiC16:0PC/C16:0C22:6PC s/ld (b) Steady-state fluorescence polarization 0.7 6 0.9
9 DiC16:0PC/C16:0C22:6PC s/ld (b) Fluorescence emission quantum yield 0.5 6 0.2
10 DiC16:0PC/C16:0C22:6PC s/ld (b) Steady-state fluorescence polarization 0.70 6 0.18
10 DiC16:0PC/C16:0C22:6PC s/ld (b) Fluorescence emission quantum yield 0.65 6 0.19
1-C16:0–2-tPnA PC 9 DiC16:0PC/C16:0C22:6PC s/ld (b) Steady-state fluorescence polarization 4.3 6 2.4
9 DiC16:0PC/C16:0C22:6PC s/ld (b) Fluorescence emission quantum yield 10.0 6 6.4
1-C18:1–2-tPnA PC 9 DiC16:0PC/C16:0C22:6PC s/ld (b) Steady-state fluorescence polarization 0.6 6 0.3
9 DiC16:0PC/C16:0C22:6PC s/ld (b) Fluorescence emission quantum yield 0.7 6 0.3
1-C16:0–2-tPnA PE 9 DiC16:0PC/C16:0C22:6PC s/ld (b) Steady-state fluorescence polarization 5.0 6 2.5
9 DiC16:0PC/C16:0C22:6PC s/ld (b) Fluorescence emission quantum yield 13.8 6 6.9
11 DiC16:0PC/diC18:2PC s/ld (b) Steady-state fluorescence polarization 4.5 6 1.4
11 DiC16:0PC/diC18:2PC s/ld (b) Fluorescence emission quantum yield 3.4 6 1.5
1-C16:0–2-tPnA PG 11 DiC16:0PC/diC18:2PC s/ld (b) Steady-state fluorescence polarization 7.2 6 14.0
11 DiC16:0PC/diC18:2PC s/ld (b) Fluorescence emission quantum yield 2.1 6 0.7
1-C18:1–2-tPnA PE 9 DiC16:0PC/C16:0C22:6PC s/ld (b) Steady-state fluorescence polarization 0.6 6 0.4
9 DPPC/C16:0C22:6PC s/ld (b) Fluorescence emission quantum yield 0.8 6 0.2
N-tPnA glucosylcerebroside 10 DiC16:0PC/C16:0C22:6PC s/ld (b) Steady-state fluorescence polarization 0.66 6 0.08
10 DiC16:0PC/C16:0C22:6PC s/ld (b) Fluorescence emission quantum yield 0.72 6 0.29
N-tPnA ceramide 10 DiC16:0PC/C16:0C22:6PC s/ld (b) Steady-state fluorescence polarization 0.59 6 0.40
10 DiC16:0PC/C16:0C22:6PC s/ld (b) Fluorescence emission quantum yield 0.45 6 0.25
1-C16:0–2-cPnA PC 9 DiC16:0PC/C16:0C22:6PC s/ld (b) Steady-state fluorescence polarization 0.6 6 0.3
9 DiC16:0PC/C16:0C22:6PC s/ld (b) Fluorescence emission quantum yield 0.6 6 0.2
10 DiC16:0PC/C16:0C22:6PC s/ld (b) Steady-state fluorescence polarization 0.70 6 0.40
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Probe Ref.c Host phase Type T (8C)d Method of determination KP(L)
10 DiC16:0PC/C16:0C22:6PC s/ld (b) Fluorescence emission quantum yield 0.63 6 0.19
1-C18:1–2-cPnA PC 9 DiC16:0PC/C16:0C22:6PC s/ld (b) Steady-state fluorescence 0.3 6 0.1
polarization
9 DiC16:0PC/C16:0C22:6PC s/ld (b) Fluorescence emission quantum yield 0.2 6 0.1
1-C16:0–2-cPnA PE 9 DiC16:0PC/C16:0C22:6PC s/ld (b) Steady-state fluorescence 1.0 6 0.4
polarization
9 DiC16:0PC/C16:0C22:6PC s/ld (b) Fluorescence emission quantum yield 1.0 6 0.2
1-C18:1–2-cPnA PE 9 DiC16:0PC/C16:0C22:6PC s/ld (b) Steady-state fluorescence 0.4 6 0.4
polarization
9 DiC16:0PC/C16:0C22:6PC s/ld (b) Fluorescence emission quantum yield 0.5 6 0.5
11 DiC16:0PC/diC18:2PC s/ld (b) Steady-state fluorescence 0.13 6 0.03
polarization
11 DiC16:0PC/diC18:2PC s/ld (b) Fluorescence emission quantum yield 0.4 6 0.3
1-C18:1–2-cPnA PG 11 DiC16:0PC/diC18:2PC s/ld (b) Steady-state fluorescence 0.3 6 0.1
polarization
11 DiC16:0PC/diC18:2PC s/ld (b) Fluorescence emission quantum yield 0.2 6 0.1
1-C18:1–2-tPnA PC 12 DiC16:0PC/diC18:2PC s/ld (b) Steady-state fluorescence 0.4 6 0.1
polarization
12 DiC16:0PC/diC18:2PC s/ld (b) Fluorescence emission quantum yield 0.9 6 0.2
1-C18:1–2-tPnA PE 12 DiC16:0PC/diC18:2PC s/ld (b) Steady-state fluorescence 0.6 6 0.6
polarization
12 DiC16:0PC/diC18:2PC s/ld (b) Fluorescence emission quantum yield 1.2 6 0.5
1-C16:0–2-cPnA PC 12 DiC16:0PC/diC18:2PC s/ld (b) Steady-state fluorescence 0.6 6 0.2
polarization
12 DiC16:0PC/diC18:2PC s/ld (b) Fluorescence emission quantum yield 1.2 6 0.4
1-C16:0–2-cPnA PE 12 DiC16:0PC/diC18:2PC s/ld (b) Steady-state fluorescence 0.8 6 0.3
polarization
12 DiC16:0PC/diC18:2PC s/ld (b) Fluorescence emission quantum yield 1.6 6 0.3
t-COPA 13 DiC14:0PC (s and ld s/ld (c) Fluorescence emission quantum yield 1.4 6 0.4
phases examined (derived from lipid-phase/aque-
independently) ous-phase partitions)
c-COPA 13 DiC14:0PC (s and ld s/ld (c) Fluorescence emission quantum yield 1.4 6 0.4
phases examined (derived from lipid-phase/aque-
independently) ous-phase partitions)
1-C16:0–2-DNS–C11:0 PE 14 DiC16:0PC/diC18:2PC s/ld (b) Steady-state fluorescence 0.08 6 0.03
polarization
1-C18:1–2-DNS–C4:0 PE 14 DiC16:0PC/diC18:2PC s/ld (b) Steady-state fluorescence 0.2 6 0.1
polarization
Prodan 15 DiC16:0PC/diC12:0PC s/ld 25 Fluorescence emission intensity 0.03
(derived from lipid-phase/aque-
ous-phase partitions)
3-(9-Anthroyloxy) stearic acid 6 DiC16:0PC/SL–PCe s/ld 25 Fluorescence quenching 0.4 6 0.08
6 DiC18:0PC/SL–PCe s/ld 25 Fluorescence quenching 0.25 6 0.06
6 Ca(diC18:1PS)2/SL–PC s/ld 25 Fluorescence quenching 0.06 6 0.01
(excess Ca2+)e
6-(9-Anthroyloxy)stearic acid 6 DiC16:0PC/SL–PCe s/ld 25 Fluorescence quenching 0.25 6 0.06
6 DiC18:0PC/SL–PCe s/ld 25 Fluorescence quenching 0.20 6 0.12
6 Ca(diC18:1PS)2/SL–PC s/ld 25 Fluorescence quenching 0.06 6 0.01
(excess Ca2+)e
9-(9-Anthroyloxy)stearic acid 6 DiC16:0PC/SL–PCe s/ld 25 Fluorescence quenching 0.25 6 0.06
6 DiC18:0PC/SL–PCe s/ld 25 Fluorescence quenching 0.25 6 0.13
6 Ca(diC18:1PS)2/SL–PC s/ld 25 Fluorescence quenching 0.06 6 0.01
(excess Ca2+)e
12-(9-Anthroyloxy)stearic acid 6 DiC16:0PC/SL–PCe s/ld 25 Fluorescence quenching 0.25 6 0.06
6 DiC18:0PC/SL–PCe s/ld 25 Fluorescence quenching 0.17 6 0.08
6 Ca(diC18:1PS)2/SL–PC s/ld 25 Fluorescence quenching 0.05 6 0.01
(excess Ca2+)e
16 DiC16:0PC/diC12:0PC s/ld Fluorescence polarization ,0
Phase Heterogeneity in Lipid Bilayer Membranes 265
Table I—Continued.
Probe Ref.c Host phase Type T (8C)d Method of determination KP(L)
12-(9-Anthroyloxy) stearic acid 4 Ca(diC18:1PS)2/SL–PC s8/ld 26 Fluorescence quenching 0.06 6 0.01
methyl ester (excess Ca2+)e
11-(9-Anthroyloxy)undecanoic 6 DiC16:0PC/SL–PCe s/ld 25 Fluorescence quenching 0.25 6 0.06
acid
6 DiC18:0PC/SL–PCe s/ld 25 Fluorescence quenching 0.20 6 0.08
6 Ca(diC18:1PS)2/SL–PC s8/ld 25 Fluorescence quenching 0.06 6 0.01
(excess Ca2+)e
16-(9-Anthroyloxy)palmitic 6 DiC16:0PC/SL–PCe s/ld 25 Fluorescence quenching 0.67 6 0.22
acid
6 DiC18:0PC/SL–PCe s/ld 25 Fluorescence quenching 0.67 6 0.22
6 Ca(diC18:1PS)2/SL–PC s8/ld 25 Fluorescence quenching 0.08 6 0.01
(excess Ca2+)e
1-Acyl-2-[12-(9- 4 Ca(diC18:1PS)2/SL–PC s8/ld 26 Fluorescence quenching 0.01 6 0.002
Anthroyloxy)stearoyl] PC (excess Ca2+)e
1-Acyl-2-[12-(9- 4 Ca(diC18:1PS)2/SL–PC s8/ld 26 Fluorescence quenching 1.0 6 0.02
Anthroyloxy)stearoyl] PS (excess Ca2+)e
C12:0DiI 17 DiC18:0PC/SL–PC s/ld 21 Fluorescence quenching 0.17 6 0.01
17 DiC16:0PC/SL–PC s/ld 21 Fluorescence quenching 1.25 6 0.16
17 Ca(diC18:1PS)2/SL–PC s8/ld 21 Fluorescence quenching 0.13 6 0.01
(excess Ca2+)e
C16:0DiI 17 DiC18:0PC/SL–PC s/ld 21 Fluorescence quenching 0.56 6 0.09
17 DiC18:0PC/SL–PC s/ld 35 Fluorescence quenching 0.67 6 0.13
17 DiC16:0PC/SL–PC s/ld 21 Fluorescence quenching 2.0 6 0.4
17 Ca(diC18:1PS)2/SL–PC s8/ld 21 Fluorescence quenching 0.17 6 0.01
(excess Ca2+)e
C18:0DiI 17 DiC18:0PC/SL–PC s/ld 21 Fluorescence quenching 11.1 6 1.2
17 DiC18:0PC/SL–PC s/ld 35 Fluorescence quenching 2.5 6 0.6
17 DiC16:0PC/SL–PC s/ld 21 Fluorescence quenching 2.9 6 0.4
17 Ca(diC18:1PS)2/SL–PC s8/ld 21 Fluorescence quenching 0.20 6 0.03
(excess Ca2+)e
C20:0DiI 17 DiC18:0PC/SL–PC s/ld 21 Fluorescence quenching 50 6 25
17 DiC18:0PC/SL–PC s/ld 35 Fluorescence quenching 6.7 6 2.7
17 DiC16:0PC/SL–PC s/ld 21 Fluorescence quenching 4.0 6 0.8
17 Ca(diC18:1PS)2/SL–PC s8/ld 21 Fluorescence quenching 0.28 6 0.04
(excess Ca2+)e
C22:0DiI 17 DiC18:0PC/SL–PC s/ld 21 Fluorescence quenching 25 6 6
17 DiC18:0PC/SL–PC s/ld 35 Fluorescence quenching 5.0 6 1.3
17 DiC16:0PC/SL–PC s/ld 21 Fluorescence quenching 1.4 6 0.2
17 Ca(diC18:1PS)2/SL–PC s8/ld 21 Fluorescence quenching 0.22 6 0.02
(excess Ca2+)e
NBD–C12:0 18 DiC18:0PC/diC12:0PC s/ld 20 Steady-state fluorescence emission 0.2 (h)/0.5 (c)f
anisotropy
18 DiC18:0PC/diC12:0PC s/ld 30 Steady-state fluorescence emission 0.2 (h)/0.6 (c)
anisotropy
NBD–C14:0 18 DiC18:0PC/diC12:0PC s/ld 20 Steady-state fluorescence emission 0.5 (h)/0.6 (c)
anisotropy
18 DiC18:0PC/diC12:0PC s/ld 30 Steady-state fluorescence emission 0.6 (h)/0.7 (c)
anisotropy
NBD–C16:0 18 DiC18:0PC/diC12:0PC s/ld 20 Steady-state fluorescence emission 1.0 (h)/0.9 (c)
anisotropy
18 DiC18:0PC/diC12:0PC s/ld 30 Steady-state fluorescence emission 1.3 (h)/1.3 (c)
anisotropy
NBD–C18:0 18 DiC18:0PC/diC12:0PC s/ld 20 Steady-state fluorescence emission 1.7 (h)/1.5 (c)
anisotropy
18 DiC18:0PC/diC12:0PC s/ld 30 Steady-state fluorescence emission 2.5 (h)/1.7 (c)
anisotropy
NBD–C18:1 18 DiC18:0PC/diC12:0PC s/ld 20 Steady-state fluorescence emission 0.1 (h)/0.5 (c)
anisotropy
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18 DiC18:0PC/diC12:0PC s/ld 30 Steady-state fluorescence emission 0.4 (h)/0.6 (c)
anisotropy
NBD–diC12:0PE 18 DiC18:0PC/diC12:0PC s/ld 20 Steady-state fluorescence emission 0.0 (h)/0.0 (c)
anisotropy
18 DiC18:0PC/diC12:0PC s/ld 30 Steady-state fluorescence emission 0.0 (h)/0.0 (c)
anisotropy
19 DiC12:0PC/ ld/ld 40 Equilibrium probe exchange between 1.4
C22:1(D13)C22:1(D13)PC vesicle populations
19 C16:0C18:1(D9)PC/ ld/ld 40 Equilibrium probe exchange between 1.2
C22:1(D13)C22:1(D13)PC vesicle populations
19 C16:1(D9)C16:1(D9)PC/ ld/ld 40 Equilibrium probe exchange between 1.8
C22:1(D13)C22:1(D13)PC vesicle populations
19 C18:1(D9)C18:1(D9)PC/ ld/ld 40 Equilibrium probe exchange between 1.4
C22:1(D13)C22:1(D13)PC vesicle populations
19 C18:1(D6)C18:1(D6)PC/ ld/ld 40 Equilibrium probe exchange between 1.6
C22:1(D13)C22:1(D13)PC vesicle populations
19 C20:1(D11)C20:1(D11)PC/ ld/ld 40 Equilibrium probe exchange between 1.4
C22:1(D13)C22:1(D13)PC vesicle populations
19 C16:0C18:1(D9)PS/ ld/ld 40 Equilibrium probe exchange between 1.2
C18:1(D9)C18:1(D9)PS vesicle populations
19 C16:0C18:1(D9)PG/ ld/ld 40 Equilibrium probe exchange between 1.10 6 0.02
C18:1(D9)C18:1(D9)PG vesicle populations
NBD–diC14:0PE 18 DiC18:0PC/diC12:0PC s/ld 20 Steady-state fluorescence emission 0.4 (h)/0.5 (c)
anisotropy
18 DiC18:0PC/diC12:0PC s/ld 30 Steady-state fluorescence emission 0.5 (h)/0.5 (c)
anisotropy
20 DiC14:0PC/cholesterol lo/ld 30 Steady-state fluorescence anisotropy 1.1
20 DiC14:0PC/cholesterol lo/ld 40 Steady-state fluorescence anisotropy 2.6
NBD–diC16:0PE 18 DiC18:0PC/diC12:0PC s/ld 20 Steady-state fluorescence emission 1.0 (h)/1.1 (c)
anisotropy
18 DiC18:0PC/diC12:0PC s/ld 30 Steady-state fluorescence emission 1.1 (h)/1.2 (c)
anisotropy
NBD–diC18:0PE 18 DiC18:0PC/diC12:0PC s/ld 20 Steady-state fluorescence emission 1.0 (h)/1.1 (c)
anisotropy
18 DiC18:0PC/diC12:0PC s/ld 30 Steady-state fluorescence emission 1.3 (h)/1.4 (c)
anisotropy
18 DiC14:0PC/cholesterol lo/ld 30 Steady-state fluorescence emission 1.0 6 0.4
anisotropy
NBD–C16:0C18:1PE 18 DiC18:0PC/diC12:0PC s/ld 20 Steady-state fluorescence emission 0.0 (h)/0.0 (c)
anisotropy
18 DiC18:0PC/diC12:0PC s/ld 30 Steady-state fluorescence emission 0.0 (h)/0.1 (c)
anisotropy
18 DiC14:0PC/cholesterol lo/ld Steady-state fluorescence emission 0.4 6 0.1
anisotropy
U-6 21 DiC14:0PC/ lo/ld Values obtained from kinetics of 0.21
diC14:0PC– probe insertion into bilayers
cholesterol (65/35)
N-(Lissamine–rhodamine B) 20 DiC14:0PC/cholesterol lo/ld 30 Excited-state lifetime and steady- 0.30
diC14:0PE state fluorescence intensity
20 DiC14:0PC/cholesterol lo/ld 40 Excited-state lifetime and steady- 0.27
state fluorescence intensity
a For a list of abbreviations please see the Appendix.
b KP(L) is always given for partition between a more ordered (solid, liquid-ordered) and a less ordered (liquid-ordered, liquid-disordered) phase, i.e.,
KP(L) 5 [A1]/[A2]; see Eq. (4) in text.
c (1) Ref. 17; (2) Ref. 31; (3) Ref. 33; (4) Ref. 16; (5) Ref. 14; (6) Ref. 22; (7) Ref. 46; (8) Ref. 59; (9) Ref. 76; (10) Ref. 51; (11) Ref. 38; (12)
Ref. 75; (13) Ref. 39; (14) Ref. 6; (15) Ref. 30; (16) Ref. 7; (17) Ref. 61; (18) Ref. 41; (19) Ref. 15; (20) Ref. 35; (21) Ref. 47.
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d (a) Temperature not specified. (b) Data were averaged over a wide range of temperatures. (c) KP was measured independently at different temperatures
for partitioning of the FLA between pure lipid phases and an aqueous phase, and the values of KP obtained, at different temperatures, were used
to calculate KP(L).
e The authors have preferred to report a “concentration ratio” instead of a KP(L) in these cases, arguing that slow diffusional redistribution of the
fluorescent amphiphile probe “trapped” in the gel or other solid phase may cause the system not to be at equilibrium. This concentration ratio is
identical to KP(L) at equilibrium. The preoccupation may be especially justified in the case of systems that have a Ca(PS)2-rich solid phase, which
may be dehydrated and considerably more highly ordered than a typical hydrated, thermotropically induced gel phase. This phase is referred to
as the s8 phase in the table. For further details see Ref. 16 and the discussion of this phase structure therein.
f Values are reported for heating (h) and cooling (c) scans.
FLA exchange between two lipid vesicle populations tives of trans- and cis-parinaric acids between these
phases by Welti and co-workers and by Rintoul et al.of distinct phase properties, in one population of which
a nontransferable quencher has been included [42,43], Partitioning of the probes occurred between an s phase
rich in diC16:0PC and an ld phase rich in C16:0C22:6PChave been used to study the equilibrium exchange
between phases of rapidly exchanging FLAs derived from coexistent in the same lipid bilayer. In these studies, KP(L)
values obtained for the same system using fluorescencephosphoglycero- or sphingolipids [15,18,53,54,72].
These rapidly exchanging FLAs are either short-chain intensity/quantum yield measurements and steady-state
fluorescence polarization measurements were shown tolipids or lipids in which one of the apolar chains was
substituted by a fluorescent derivative whose charge or be comparable. Steady-state polarization of fluorescence
was also used in a recent study [41] of the partitioningpolarity forced this chain to expose the fluorophore to
the bilayer–water interface [12]. In the present context of a homologous series of NBD–amino alkanes and
NBD–PEs, of varying chain lengths (between C12:0 andthe results of this work are of interest due to the demon-
stration that FLA partitioning is not necessarily identical C18:0) and degrees of saturation (C18:0 and C18:1(D9cis)),
between coexisting s and ld phases in lipid bilayers pre-for all phases of the same designation [for example, ld
phases (see Ref. 15) and charged versus neutral membrane pared from a mixture of diC12:0PC and diC18:0PC. This
study was extended to membranes made from a binarysurfaces (see Ref. 18)] and the fact that small but signifi-
cant differences in partition behavior (within a factor of mixture of diC14:0PC and cholesterol with a coexistence
of ld and lo phases in which the partitioning of NBD–two- to three fold) may result from differences in probe
headgroup characteristics [18]. diC18:0PE and NBD–C18:1(D9cis))PC was examined. A sim-
ilar study using NBD-diC14:0PC was reported by LouraFluorescence emission intensity or quantum yields
can be different for FLAs in different phases, be they et al. [35].
A third widely used method for determination of thelipid or aqueous. These differences in emission intensities
(quantum yields) have been exploited in some of the KP(L) for FLA partitioning between coexistent s and ld
membrane phases is the quenching of fluorescence of theearliest work in this field that studied the partition of
trans- and cis-parinaric acids [59] and perylene [17] FLA by a spin-labeled phospholipid [32] or a phospho-
lipid with a brominated acyl chain [55] which is thebetween coexisting s and ld membrane phases. The
method developed by Sklar and co-workers was later principal chemical constituent of the ld phase. If the con-
centration of the quencher in the ld phase is very high,used by Welti and co-workers [38,75,76] to study the
partition of several phospholipid derivatives that included static quenching of the FLA fluorescence may result.
Feigenson and co-workers [14,16,22,32,33,61] have usedtrans- and cis-parinaric acid in their structure and by
Rintoul et al.[51] to study the partition of N-trans-parinar- this method to study the partition of a series of FLAs
between s phases constituted primarily of saturated-chainoylsphingosine (ceramide) and N-trans-parinaroylgluco-
sylcerebroside between coexistent s and ld phases. PCs (in which the phase is thermally induced), or divalent
metal ion-induced diC18:1cisPS solid phases, and a spin-Steady-state fluorescence anisotropy (polarization)
was used in the first determination of the equilibrium labeled PC-rich ld phase. A drawback of this method is
that one of the phases, usually the ld phase, has to bepartitioning of a fluorophore (DPH) between s-phase
diC18:0PC and ld-phase diC14:0PC liposomes by Lentz et composed almost totally of the spin-labeled phospholipid
derivative. Although it has been shown that this derivativeal.[31]. Its use was then extended to the study of trans-
and cis-parinaric acid partitioning between s and ld fluid forms hydrated lipid bilayers and vesicles [32], little else
is known about the physical characteristics of this phase,phases by Sklar et al. [59] and applied to the partitioning
of several glycerophospholipid and sphingolipid deriva- and in any case, its relevance to phases that may exist
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in biological systems is debatable. The partition behaviors cosylceramide derivatives (by about a factor of 2) and
reduced by having unsaturation in the sn-1 acyl chain.of a homologous series of (9-anthroyloxy)-fatty acids
Despite the large volume of data accumulated overwith the anthroyloxy group located at various positions
the years concerning the partitioning of FLAs betweenin the fatty acid chain [22] and a homologous series of
coexistent lipid phases, there are relatively few generaldialkyl indocarbocynanines with saturated alkyl chain
conclusions of predictive value that can be derived fromlengths of between 12 and 18 carbon atoms [61] between
it. It appears to be reasonably clear that FLA preferences and ld phases rich in the spin-labeled phospholipid are
for a fluid phase has to do with the length of the apolarsummarized in Table I. Silvius and co-workers [72,73]
portion of the molecule and how well it “fits” into thehave used the spin-labeled quencher approach to study
lipid packing lattice. Thus long fully saturated chainsthe comparative partitioning of several FLAs between
favor partitioning into ordered phases (domains) andcoexisting phases in lipid bilayers made from ternary
shorter chains have an increasing tendency to partitionmixtures of phosphoglycero- or sphingolipids, a spin-
into less ordered phases (domains). Unsaturation of thelabeled PC derivative, and cholesterol at a 0.33 mole
cis- type in the apolar chains of the FLA makes themfraction. At the high cholesterol content of the membranes
prefer disordered phases; the greater the amount of unsat-it is probable that the spin-labeled PC-rich phase also
uration, the greater the preference. Unsaturation of thecontains an appreciable amount of cholesterol. The phase
trans type predisposes the FLA to prefer a more orderedcoexistence in the bilayers studied is presented by the
phase, though this may not always be the case. Bulkyauthors as being of the lo/ld type but this has, in our
fluorophores in the apolar portion of the FLA moleculejudgment, not been clearly demonstrated. In any case, it
are more or less indifferent to the host phase if they haveis probable that a saturated long-chain PC/cholesterol or
an all-trans rigid configurations, are relatively apolarsphingolipid/cholesterol lo phase coexists in these systems
themselves, and/or are located sufficiently close to thewith a spin-labeled PC-rich phase that also contains an
bilayer midplane. Commonly used fluorescent lipid deriv-appreciable amount of cholesterol and may be of the lo
atives, such as NBD-PCs and Bodipy-PCs, that haveor of the ld type. This study is of particular interest since bulky aromatic polar groups attached to their acyl chainsit is one of the first attempts in this sort of study to model
prefer disordered phases. The FLA headgroup does notthe cell plasma membrane and “raft”-like phases. Two
seem to play a major role in the behavior of the probestypes of FLAs have been used: (1) headgroup-labeled (within a factor of about 2 in the values of the KP(L)),FLAs, some derived from phosphatidylethanolamines
with a few notable exceptions. As would be expected,[73]; and (2) acyl chain-modified modified FLAs derived different phases of the same general description (s, lo, orfrom various phosphoglycero- and sphingolipids [72]. In ld) are not necessarily identical, partly as a consequencethe first set [73], the partitioning of the amphiphiles is
of the constituent lipid polar portions to participate or
reported as a relative value with a di-C18:0 FLA having not in hydrogen bonding or as a consequence of the
the identical headgroup. The general conclusion is that
surface charge and sometimes because of the packing
increasing the chain length increases the tendency to parti-
order in the s phase. The characteristics of the FLA
tion into a more ordered phase and increasing the unsatu- (hydrogen bonding, charge of polar portion, nature of
ration has the opposite effect. Low-temperature detergent apolar portion) then play a role in its partition behavior.(Triton X-100) solubilization of large unilamellar vesicles A serious deficiency in the available literature is the lack
with one of the probes showed some correlation between of information on the temperature dependence of partition
the degree of “detergent insolubility” of the probe and behavior. Most reports do not specify the temperatures
its relative partitioning into a more ordered phase. The at which the studies were performed, others average
second set of experiments [72] reported the relative pref- results over a wide range of temperatures, and still others
erence for a more ordered phase for a series of phospho- determine KP for the partitioning of an FLA between
glycero- and sphingolipid derivatives in which the sn-2 an aqueous phase and lipid phases at widely different
acyl chain was replaced by a 3-(4-(6-phenyl-all-trans- temperatures to obtain a value of KP(L) for partition
1,3,5-hexatrienyl)phenyl)propanoyl- group. The refer- between two phases. The latter two approaches are clearly
ence derivative was a phosphatidylcholine with a tetrade- physically wrong since KP and KP(L) are temperature-
canoyl chain in the sn-1 position. The general conclusion dependent quantities. Detailed studies of the temperature
was that the effect of the headgroup structure on the dependence of KP(L) would permit conclusions about par-
partitioning behavior of the probes is small, the preference tition energetics which would have important pre-
dictive value.for more ordered phases being notably enhanced for gly-
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APPENDIX undecanoyl-
DPH 1,6-Diphenylhexa-1,3,5-(all-
trans)-triene;Abbreviations and Nomenclature
e
l(ex)
t Molar absorptivity of the ith
component at the wave-ai Amplitude of the ith component
AL Fluorescent lipid amphiphile in length of excitation
Fi Emission quantum yield of thea membrane
AW Fluorescent lipid amphiphile in ith component
fi Fraction of the total emissionaqueous solution
CA Total concentration of a fluores- intensity originating from
the phase icent lipid amphiphile
CP Total concentration of a lipid- F(t) Time-dependent intensity of flu-
orescencebinding protein
CS Surface concentration (moles/ FLA Fluorescent lipid amphiphile
I l(ex)i Number of quanta absorbed byarea) of a fluorescent lipid
amphiphile in a membrane the ith component at the
wavelength of excitationCn:xDiI 1,18-Dialkyl-3,3,38,38-
tetramethylindocarbocya- KP Equilibrium partition coefficient
for partitioning between anine in which the alkyl groups
have n carbon atoms and x membrane and an aqueous
phasedouble bonds
Cx:y n-Acyl or n-alkyl chains (consid- KP(L) Equilibrium partition coefficient
for partitioning between twoered to be n-acyl when refer-
ring to lipids) with x carbon membrane phases
kfi Radiative rate constant for theatoms and y double bonds
(considered to be of the cis ith component
k+, k2 Reaction rate constants in the for-configuration unless speci-
fied otherwise) ward and reverse direction,
respectivelyCx:yCx8:y8 1-n-Acyl(x:y)-2-n-acyl(x8:y8)
glycerolipids with n-acyl lem, lex Fluorescence emission and exci-
tation wavelengthschains having x or x8 carbon
atoms and y or y8 unsaturated ld Liquid-disordered phase
lo Liquid-ordered phasebonds, respectively, in the sn-
1 and sn-2 positions NBD N-(7-Nitrobenzoxa-2,3-diazol-4-
yl)1-C18:0–2-DPH–PC 1-Octadecanoyl–2-[[2-[4-(6-
phenylhexa-1,3,5-all-trans- NBD–Cn:x N-(7-Nitrobenzoxa-2,3-diazol-4-
yl)–amino alkane in whichtrienyl)-phenyl]ethyl] car-
bonyl]–3-sn- the alkyl moiety has n carbon
atoms and x double bondsglycerophosphocholine
c-COPA Octadeca-8-cis-10,12,14,16-all- with a cis configuration
NBD–Cn:xCm:yPE N-(7-Nitrobenzoxa-2,3-diazol-4-trans-pentaenoic acid
cPnA Octadeca-9,11,13,15- yl)–amino
glycerophosphoethanolaminecis,trans,trans, cis-tetrae-
noic acid or octadeca- in which the acyl chain attached
to the glycerol sn-1 position9,11,13,15-cis,trans,-
trans,cis-tetraenoyl- has n carbon atoms with x
double bonds and the acylDNS–C4:0 5-N,N-
Dimethylaminonaphthalene- group attached to the glyc-
erol sn-1 position has m carbonsulfonamido–4-butanoyl-
DNS–C11:0 5-N,N-Dimethylamino naphtha- atoms with y double bonds,
both with a cis configurationlenesulfonamido–11-
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v+, v2 Reaction rates in the forward andP Lipid-binding protein
PA Complex of a fluorescent lipid reverse direction, respec-
tivelyamphiphile bound to a lipid-
binding protein yl(em)i Fluorescence intensity of a fluor-
ophore in phase i collectedPC 1,2-
Diacylglycerophosphocho- at lem/total fluorescence inten-
sity of the fluorophore inline, or phosphatidylcholine
PE 1,2- phase i
Diacylglycerophosphoetha-
nolamine, or phosphatidyleth-
anolamine
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